International Journal of Preventive Medicine

REVIEW ARTICLE
Year
: 2021  |  Volume : 12  |  Issue : 1  |  Page : 41-

Systematic review and meta-analysis on quality of life in diabetic patients in Iran


Moloud Fakhri1, Mohsen Abdan2, Melina Ramezanpour3, Ali Hasanpour Dehkordi4, Diana Sarikhani2 
1 Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran Sari, University of Medical Sciences, Sari, Iran
2 Research Center for Environmental Determinants of Health (RCEDH), School of Public Health, Kermanshah Uninversity of Medical Sciences, Kermanshah, Iran
3 Medical Student at school of medicine, Mazandaran University of Medical Sciences, Sari, Iran
4 Social Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran

Correspondence Address:
Ali Hasanpour Dehkordi
Social Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran
Iran
Diana Sarikhani
Research Center for Environmental Determinants of Health (RCEDH), School of Public Health, Kermanshah Uninversity of Medical Sciences, Kermanshah
Iran

Background: Diabetes is the fifth leading cause of death in the world, which reduces the patients' quality of life (QOL) and is considered as an important subject especially in medicine and medical community. The present study aimed at investigating the QOL of diabetic patients in Iran through meta-analysis. Methods: The search was conducted using relevant keywords in national and international databases including Iranmedex, SID, Magiran, IranDoc, Medlib, Science Direct, PubMed, Scopus, Cochrane, Embase, Web of Science. Questionnaires WHOQOL, SF-36, SF-20, DQOL, QOL, PedsQL, ADDQOL, D-39, DQOL-BCI, SWED-QUAL, IRDQOL, PHG-2, EQ-5D, and IDQOL-BCI were used to assess the QOL. Heterogeneity of studies was assessed using I2 index. Data were analyzed using STATA version 11. Results: In 96 studies of 17,994 people, the mean score of QOL in diabetic patients was based on the questionnaires WHOQOL [66.55 (95% CI: 45.83, 87.26)], D-39 [129.43 (95%CI: 88.77, 170.10)], SF-36 [65.64 (95% CI: 59.82, 71.46)], SF-20 [46.50 (95% CI: 37.19, 55.81], DQOL [61.19 (95% CI: 35.73, 86.66)], QOL [117.91 (95% CI: -62.97, 298.79)], PedsQL [34.36 (95% CI: -31.49, 100.22)], ADDQOL [41.76 (95% CI: 12.01-71.50)], SWED-QUAL [59.19 (95% CI: 21.15, 97.23)], IRDQOL [105.92 (95% CI: 102.73, 109.10)], PHG-2 [61.00 (95%CI: 59.63, 62.37)], EQ-5D [0.62 (95% CI: 0.61, 0.64)], DQOL-BCI [3.40 (95% CI: 3.31, 3.49)], and IDQOL-BCI [22.63 (95% CI: -2.38, 47.64)]. Conclusions: The QOL of diabetic patients was evaluated according to different types of questionnaires and the QOL of diabetic patients was found to be lower than normal population.


How to cite this article:
Fakhri M, Abdan M, Ramezanpour M, Dehkordi AH, Sarikhani D. Systematic review and meta-analysis on quality of life in diabetic patients in Iran.Int J Prev Med 2021;12:41-41


How to cite this URL:
Fakhri M, Abdan M, Ramezanpour M, Dehkordi AH, Sarikhani D. Systematic review and meta-analysis on quality of life in diabetic patients in Iran. Int J Prev Med [serial online] 2021 [cited 2022 Jan 29 ];12:41-41
Available from: https://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=41;epage=41;aulast=Fakhri;type=0